Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: LOJAIMIESS — Supplemental Application (Xiromed LLC)

View source ↗

Summary

FDA approved a supplemental application for LOJAIMIESS (levonorgestrel and ethinyl estradiol tablets) from Xiromed LLC. The product is a generic combined oral c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS)

Snippet

SUPPL AP for LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS)